Jay Lichter's Insider Trades & SAST Disclosures
Jay Lichter's most recent trade in Janux Therapeutics Inc was a trade of 3,815 Common Stock done at an average price of $46.7 . Disclosure was reported to the exchange on Sept. 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jay Lichter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.68 per share. | 13 Sep 2024 | 3,815 | 7,000 | - | 46.7 | 178,084 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 13 Sep 2024 | 1,868 | 8,868 | - | 17 | 31,756 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 1,868 | 27,138 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.22 per share. | 13 Sep 2024 | 778 | 10,424 | - | 13.2 | 10,285 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.73 per share. | 13 Sep 2024 | 778 | 9,646 | - | 10.7 | 8,348 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 778 | 11,308 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 778 | 11,308 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.80 per share. | 13 Sep 2024 | 391 | 10,815 | - | 39.8 | 15,562 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 391 | 7,682 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 7,083 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 691,525 | 3,340,018 | - | 54.8 | 37,860,994 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 677,279 | 3,271,216 | - | 54.7 | 37,081,025 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 131,196 | 633,673 | - | 54.8 | 7,182,981 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.87 per share. | 13 Nov 2023 | 849,854 | 849,854 | - | 5.9 | 4,988,643 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 2,696,843 | 2,696,843 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 2,382,191 | 3,713,006 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 2,105,264 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 1,859,634 | 0 | - | - | Series Seed 2 Convertible Preferred Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 1,153,238 | 3,850,081 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 1,138,665 | 1,330,815 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 900,264 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 888,888 | 0 | - | - | Series Seed Convertible Preferred Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 674,211 | 4,387,217 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 15 Jun 2021 | 629,411 | 4,479,492 | - | 17 | 10,699,987 | Common Stock |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | 15 Jun 2021 | 526,316 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges